Companies: 10,795·Total market cap: $144.5T
X4 Pharmaceuticals, Inc.

X4 Pharmaceuticals, Inc.

XFORNASDAQHealthcare● Active
$3.71
$-0.12(-3.13%)
Market Cap$349926072
P/E Ratio
52W High$4.83
52W Low$1.35
Overview

X4 Pharmaceuticals, Inc. (XFOR) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · XFOR · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-4.54xfor eps ttm · xfor earnings per shareEarnings history
PE Ratio (TTM)xfor pe ratio ttm · xfor price to earningsPE Ratio deep dive
Revenue (TTM)$9.0Mxfor revenue ttm · xfor annual revenueFull revenue history
Dividend YieldNo Dividenddoes xfor pay dividends · xfor dividend yieldDividend history
Shares Outstanding42.3Mxfor shares outstanding · xfor floatShares outstanding history
Next EarningsAug 6, 2026Est.xfor earnings date · xfor next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$35.1M▲ +1273.21% YoY
202320242025
x4 pharmaceuticals, inc. revenue · xfor revenue 2025
FY 2025Net Income-$79.2M▼ 111.48% YoY
202320242025
x4 pharmaceuticals, inc. net income · xfor profit 2025
FY 2025EPS$-1.87▲ +66.55% YoY
202320242025
xfor eps · x4 pharmaceuticals, inc. earnings per share 2025
TTM:Revenue: $9.0MNet Income: -$99.7MEPS: $-4.54View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy13 analystsis xfor a buy · xfor analyst rating
Strong Buy
0
Buy
12
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$12.00Low
$3.71Current
$12.00Avg Target223.45% upside
$12.00High
xfor price target · xfor 12 month forecast

Total: 13 · Buy rate: 92.3%

The XFOR analyst consensus is Buy, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $12.00, representing +223.45% upside from the current price of $3.71.

Stock Performance

Full History
1D-3.13%
1W-6.08%
1M-16.25%
3M-10.60%
YTD-7.25%
1Y-10.39%
5Y-98.61%

About X4 Pharmaceuticals, Inc.

CEOAdam R. Craig
IPO DateNov 16, 2017
Employees143
CountryUS

X4 Pharmaceuticals, Inc. is a biopharmaceutical firm committed to the discovery, development, and commercialization of innovative therapies for uncommon immune system disorders. Its primary drug candi…

what is x4 pharmaceuticals, inc. · xfor stock overview · x4 pharmaceuticals, inc. company profile · who is x4 pharmaceuticals, inc. ceo · xfor NASDAQ · x4 pharmaceuticals, inc. headquarters · x4 pharmaceuticals, inc. business segments

About Stock Overview & Key Data

X4 Pharmaceuticals, Inc. (XFOR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Nov 16, 2017. As of the latest trading session, XFOR stock price is $3.71, with a market capitalization of $349.9M. The stock has returned -10.39% over the past 12 months and -7.25% year-to-date.

According to 13 Wall Street analysts, the consensus rating for X4 Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $12.00. In fiscal year 2025, X4 Pharmaceuticals, Inc. reported revenue of $35.1M and net income of -$79.2M. For detailed data — including X4 Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, X4 Pharmaceuticals, Inc. (XFOR) stock price is $3.71. The stock is traded on NASDAQ under the ticker symbol XFOR. The 52-week range is $1.35 – $4.83.

XFOR stock priceXFOR quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice